Stopping mesalamine while on stronger IBD treatments
Part of Digestive system clinical trials.
This study looks at whether it's safe to stop taking mesalamine (a drug that helps control inflammation in the gut) for people with ulcerative colitis or Crohn's disease who are already on stronger treatments like biologics or immunomodulators. If you're doing well, this might reduce your daily pill burden.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have ulcerative colitis or Crohn's disease.
- You have been taking a biologic or immunomodulator for at least 3 months.
- You have been on the same dose of mesalamine (5-ASA) for at least 3 months.
- Your disease has been in remission (minimal symptoms) for at least 3 months.
- You are 19 years or older.
- You have not had any recent IBD-related hospital stays or surgery in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether it is safe to stop taking an immunosuppressant medication in older adults (60+) with ulcerative colitis that has been in remission for a long time. By stopping the drug, they hope to reduce side effects while keeping the disease under control.
This trial tests whether people with ulcerative colitis who have been in deep remission (no signs of active disease) can safely reduce or stop their current medication. It aims to find out if careful monitoring can keep them healthy without full-dose treatment.
This study tests whether it is safe to stop taking acid-reducing pills (PPIs) for people with inactive IBD. If you have been on a PPI for over 6 months and your IBD is stable, you may be able to join.
This trial tests an oral study drug called Hemay005 for people with moderate to severe ulcerative colitis (UC) who have not responded well to other treatments. If you join, you will receive either the study drug or a placebo (inactive pill) to see if it helps reduce symptoms and heal the gut lining.
This trial compares two oral medicines — etrasimod (a newer drug that works on the immune system) and mesalazine (a standard anti-inflammatory) — in Chinese adults with active ulcerative colitis. It aims to see which is better at controlling symptoms and is safer. If you have mild to moderate active UC, you may join.
This study tests an investigational pill for people with moderate-to-severe ulcerative colitis that has not improved with standard treatments. The goal is to see if the pill can reduce symptoms like bloody stools and frequent bowel movements.
Hear when a new Crohn's Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.